Immunologist and vaccine researcher Zhou Xing explains how he and a large team of colleagues mobilized 20 years of vaccine research to rapidly develop and test two new second-generation COVID-19 vaccine candidates.
The Robert E. Fitzhenry Vector Laboratory is the first facility of its kind in Canada and one of a few with the capacity to develop and produce viral-vectored vaccines for clinical testing.
Immune memory is an essential component of human survival, enabling the body to more effectively fight off infections that are caused by dangerous pathogens.
McMaster logo
McMaster logo
